The tumor suppressive role of MiRNA-509-5p by targeting FOXM1 in non-small cell lung cancer

Cellular Physiology and Biochemistry

Volumn 38, Issue 4, 2016, Pages 1435-1446

  Ma, Ning ^a   Zhang, Weihua ^a   Qiao, Chenhui ^a   Luo, Hong ^a   Zhang, Xin ^a   Liu, Donghai ^a   Zang, Suhua ^a   Zhang, Liang ^a   Bai, Jingyun ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Apoptosis; FOXM1; Invasion; Migration; MiRNA 509 5p; Non small cell lung cancer

Indexed keywords

LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 509 5P; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXM1; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; 3' UNTRANSLATED REGION; ANTAGOMIR; CADHERIN; FORKHEAD BOX PROTEIN M1; FOXM1 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL INVASION; CELL LEVEL; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CLONOGENESIS; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER CELL LINE; LUNG FIBROBLAST; METASTASIS; MICRORNA CELL LEVEL; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; TUMOR INVASION; UPREGULATION; A-549 CELL LINE; ANTAGONISTS AND INHIBITORS; CELL MOTION; CELL SURVIVAL; GENETICS; LUNG TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; SEQUENCE ALIGNMENT; TUMOR CELL LINE; WESTERN BLOTTING;

3' UNTRANSLATED REGIONS; A549 CELLS; ANTAGOMIRS; BASE SEQUENCE; BLOTTING, WESTERN; CADHERINS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; FORKHEAD BOX PROTEIN M1; GENES, REPORTER; HUMANS; LUNG NEOPLASMS; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; VIMENTIN;

EID: 84964033706     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000443086     Document Type: Article

References (39)

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87-108
2. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc 2008; 83: 584-594
3. Paez JG, Janne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science 2004; 304: 1497-1500
4. Eccles SA, Welch DR. Metastasis: recent discoveries and novel treatment strategies. Lancet 2007; 369: 1742-1757
5. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531
6. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866
7. Miyashita A, Fukushima S, Nakahara S, Yamashita J, Tokuzumi A, Aoi J, Ichihara A, Kanemaru H, Jinnin M, Ihn H. Investigation of FOXM1 as a Potential New Target for Melanoma. PLoS One 2015; 10: e144241
8. Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011; 11: 849-864
9. Li J, Yu T, Cao J, Liu L, Liu Y, Kong HW, Zhu MX, Lin HC, Chu DD, Yao M, Yan MX. MicroRNA-148a Suppresses Invasion and Metastasis of Human Non-Small Cell Lung Cancer. Cell Physiol Biochem 2015; 37: 1847-1856
10. He Z, Xia Y, Pan C, Ma T, Liu B, Wang J, Chen L, Chen Y. Up-Regulation of MIR-452 Inhibits Metastasis of Non-Small Cell Lung Cancer by Regulating BMI1. Cell Physiol Biochem 2015; 37: 387-398
11. Deng W, Yan M, Yu T, Ge H, Lin H, Li J, Liu Y, Geng Q, Zhu M, Liu L, He X, Yao M. Quantitative proteomic analysis of the metastasis-inhibitory mechanism of MIR-193a-3p in non-small cell lung cancer. Cell Physiol Biochem 2015; 35: 1677-1688
12. Zhang L, Qian J, Qiang Y, Huang H, Wang C, Li D, Xu B. Down-regulation of MIR-4500 promoted non-small cell lung cancer growth. Cell Physiol Biochem 2014; 34: 1166-1174
13. Hu X, Zhang F, Liu XR, Wu YT, Ni YM. Efficacy and potential microRNA mechanism for computed tomography-guided percutaneous radiofrequency ablation of primary lung cancer and lung metastasis from liver cancer. Cell Physiol Biochem 2014; 33: 1261-1271
14. Wu N, Zhang C, Bai C, Han YP, Li Q. MIR-4782-3p inhibited non-small cell lung cancer growth via USP14. Cell Physiol Biochem 2014; 33: 457-467
15. Dong W, Yongjun L, Nan D, Junyun W, Qiong Y, Yaran Y, Yanming L, Xiangdong F, Hua Z. Molecular networks and mechanisms of epithelial-mesenchymal transition regulated by miRNAs in the malignant melanoma cell line. Yi Chuan 2015; 37: 673-682
16. Xing F, Sharma S, Liu Y, Mo YY, Wu K, Zhang YY, Pochampally R, Martinez LA, Lo HW, Watabe K. MIR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-Alpha. Oncogene 2015; 34: 4890-4900
17. Zhang WB, Pan ZQ, Yang QS, Zheng XM. Tumor suppressive MIR-509-5p contributes to cell migration, proliferation and antiapoptosis in renal cell carcinoma. Ir J Med Sci 2013; 182: 621-627
18. Ren ZJ, Nong XY, Lv YR, Sun HH, An PP, Wang F, Li X, Liu M, Tang H. MIR-509-5p joins the Mdm2/p53 feedback loop and regulates cancer cell growth. Cell Death Dis 2014; 5: e1387
19. Gao J, Zou Z, Gao J, Zhang H, Lin Z, Zhang Y, Luo X, Liu C, Xie J, Cai C. Increased expression of HMGB3: a novel independent prognostic marker of worse outcome in patients with esophageal squamous cell carcinoma. Int J Clin Exp Pathol 2015; 8: 345-352
20. Nie P, Hu W, Zhang T, Yang Y, Hou B, Zou Z. Synergistic Induction of Erlotinib-Mediated Apoptosis by Resveratrol in Human Non-Small-Cell Lung Cancer Cells by Down-Regulating Survivin and Up-Regulating PUMA. Cell Physiol Biochem 2015; 35: 2255-2271
21. Zou Z, Yuan Z, Zhang Q, Long Z, Chen J, Tang Z, Zhu Y, Chen S, Xu J, Yan M, Wang J, Liu Q. Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells. Autophagy 2012; 8: 1798-1810
22. Jiang S, Zou Z, Nie P, Wen R, Xiao Y, Tang J. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells. PLoS One 2015; 10: e132880
23. Mi YJ, Geng GJ, Zou ZZ, Gao J, Luo XY, Liu Y, Li N, Li CL, Chen YQ, Yu XY, Jiang J. Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells. PLoS One 2015; 10: e120426
24. Lou YF, Zou ZZ, Chen PJ, Huang GB, Li B, Zheng DQ, Yu XR, Luo XY. Combination of gefitinib and DNA methylation inhibitor decitabine exerts synergistic anti-cancer activity in colon cancer cells. PLoS One 2014; 9: e97719
25. Zou ZZ, Nie PP, Li YW, Hou BX, Rui-Li, Shi XP, Ma ZK, Han BW, Luo XY. Synergistic induction of apoptosis by salinomycin and gefitinib through lysosomal and mitochondrial dependent pathway overcomes gefitinib resistance in colorectal cancer. Oncotarget DOI: 10.18632/oncotarget.5628
26. Durer U, Hartig R, Bang S, Thim L, Hoffmann W. TFF3 and EGF induce different migration patterns of intestinal epithelial cells in vitro and trigger increased internalization of E-cadherin. Cell Physiol Biochem 2007; 20: 329-346
27. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674
28. Rolfo C, Fanale D, Hong DS, Tsimberidou AM, Piha-Paul SA, Pauwels P, Van Meerbeeck JP, Caruso S, Bazan V, Cicero G, Russo A, Giovannetti E. Impact of microRNAs in resistance to chemotherapy and novel targeted agents in non-small cell lung cancer. Curr Pharm Biotechnol 2014; 15: 475-485
29. Chang L, Shrestha S, LaChaud G, Scott MA, James AW. Review of microRNA in osteosarcoma and chondrosarcoma. Med Oncol 2015; 32: 613
30. Bracken CP, Khew-Goodall Y, Goodall GJ. Network-Based Approaches to Understand the Roles of MIR-200 and other microRNAs in Cancer. Cancer Res 2015; 75: 2594-2599
31. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297
32. Shi M, Cui J, Xie K. Signaling of miRNAs-FOXM1 in cancer and potential targeted therapy. Curr Drug Targets 2013; 14: 1192-1202
33. Li J, Wang Y, Luo J, Fu Z, Ying J, Yu Y, Yu W. MIR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells. FEBS Lett 2012; 586: 3761-3765
34. Bella L, Zona S, Nestal DMG, Lam EW. FOXM1: A key oncofoetal transcription factor in health and disease. Semin Cancer Biol 2014; 29: 32-39
35. Fan Q, Cai Q, Xu Y. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer. Oncotarget 2015; 6: 27688-27699
36. Xu K, Liu X, Mao X, Xue L, Wang R, Chen L, Chu X. MicroRNA-149 suppresses colorectal cancer cell migration and invasion by directly targeting forkhead box transcription factor FOXM1. Cell Physiol Biochem 201535: 499-515
37. Anders L, Ke N, Hydbring P, Choi YJ, Widlund HR, Chick JM, Zhai H, Vidal M, Gygi SP, Braun P, Sicinski P A systematic screen for CDK4/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell 2011; 20: 620-634
38. Bowman A, Nusse R. Location, location, location: FoxM1 mediates beta-catenin nuclear translocation and promotes glioma tumorigenesis. Cancer Cell 2011; 20: 415-416
39. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011; 147: 275-292